Metabolic & obesity · Phase I

Top sponsors

• NovoThirteen 27 programs
• Sunshine Guojian Pharmaceutical 10 programs
• Anaxis Pharma 9 programs
• ENANTA PHARMACEUTICALS 7 programs
• First People's Hospital 6 programs
• Regeneron UK 6 programs
• United Therapeutics Europe 6 programs
• Eli Lilly and 5 programs
• Boehringer Ingelheim 4 programs
• HOFFMANN-LA ROCHE 4 programs
• BRIGHT MINDS BIOSCIENCES 3 programs
• Chinese Academy of 3 programs

1. Erythromycin lactobionate

   ADIAL PHARMACEUTICALS, INC.

   Diabetes Mellitus, Type 1

   phase 1 · small molecule · completed

   1 trial →

2. FT-003

   The First People's Hospital of Lianyungang

   Diabetic Macular Edema

   phase 1 · gene therapy · active

   1 trial →

3. Faster Aspart

   Novo Nordisk A/S

   Diabetes Mellitus, Type 1

   phase 1 · small molecule · completed

   1 trial →

4. Fluconazole

   ENANTA PHARMACEUTICALS INC

   NASH - Nonalcoholic Steatohepatitis

   phase 1 · small molecule · completed

   1 trial →

5. GL-ULI-1001

   Lacuna Pharma Pty Ltd

   Type 2 Diabetes Mellitus

   phase 1 · other · active

   1 trial →

6. GL-ULI-1001

   Lacuna Pharma Pty Ltd

   Type 2 Diabetes Mellitus

   phase 1 · other · active

   1 trial →

7. GR-MD-02

   GALECTIN THERAPEUTICS INC

   Non-Alcoholic Steatohepatitis (NASH)

   phase 1 · small molecule · completed

   1 trial →

8. GZR33-T1D-US101

   Lacuna Pharma Pty Ltd

   Type 1 diabetes Mellitus

   phase 1 · other · active

   1 trial →

9. Garetosmab

   Regeneron UK Limited

   Obesity

   phase 1 · small molecule · terminated

   1 trial →

10. Glucagon

    United Therapeutics Europe Ltd

    Type 1 Diabetes Mellitus With Hypoglycemia

    phase 1 · small molecule · completed

    1 trial →

11. Glucose

    United Therapeutics Europe Ltd

    Diabetes Mellitus

    phase 1 · other · completed

    1 trial →

12. HEC73077 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Diabetic Nephropathy

    phase 1 · small molecule · completed

    1 trial →

13. HEC96719

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 · small molecule · completed

    1 trial →

14. HEC96719 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 · small molecule · completed

    1 trial →

15. HMS5552

    Hua Medicine Limited

    Type II Diabetes Mellitus

    phase 1 · small molecule · completed

    1 trial →

16. Huafu Shengji Ointment

    Universal Integrated

    Diabetic Foot

    phase 1 · small molecule · active

    1 trial →

17. Humalog

    HALOZYME THERAPEUTICS, INC.

    Diabetes Mellitus

    phase 1 · small molecule · completed

    1 trial →

18. I8H-MC-BDDG

    Eli Lilly Co.

    Type 2 Diabetes Mellitus

    phase 1 · other · active

    1 trial →

19. ISIS 325568

    IONIS PHARMACEUTICALS INC

    Type 2 Diabetes Mellitus

    phase 1 · small molecule · completed

    1 trial →

20. ISIS 388626

    IONIS PHARMACEUTICALS INC

    Type 2 Diabetes Mellitus

    phase 1 · small molecule · completed

    1 trial →

21. Insulin Lispro

    HALOZYME THERAPEUTICS, INC.

    Diabetes Mellitus

    phase 1 · small molecule · completed

    1 trial →

22. Insulin aspart

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    phase 1 · small molecule · completed

    1 trial →

23. Insulin degludec injection, RD15003

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Type 2 Diabetes

    phase 1 · mab · completed

    1 trial →

24. Investigating how NNC0487-0111 regulates insulin in adults with type 2 diabetes

    NovoThirteen

    Type 2 Diabetes

    phase 1 · other · active

    1 trial →

25. J1I-MC-GZQF

    Eli Lilly Co.

    Type 2 Diabetes Mellitus

    phase 1 · other · active

    1 trial →

26. J1I-MC-GZQG

    Eli Lilly Co.

    Diabetes Mellitus

    phase 1 · other · active

    1 trial →

27. J4P-MC-IYAB

    Eli Lilly Co.

    Type 1 Diabetes Mellitus

    phase 1 · other · active

    1 trial →

28. J6B-MC-YKAA

    Eli Lilly Co.

    Healthy, Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

    phase 1 · other · active

    1 trial →

29. LGD-6972

    LIGAND PHARMACEUTICALS INC

    Type 2 Diabetes Mellitus

    phase 1 · small molecule · completed

    2 trials →

30. LGD-6972 Solution

    LIGAND PHARMACEUTICALS INC

    Type 2 Diabetes Mellitus (T2DM)

    phase 1 · small molecule · completed

    1 trial →

31. LX4211

    LEXICON PHARMACEUTICALS, INC.

    Type 2 Diabetes Mellitus

    phase 1 · small molecule · completed

    2 trials →

32. LY3532226

    Eli Lilly and Company

    Obesity

    phase 1 · small molecule · completed

    1 trial →

33. Liraglutide injection,RD12014

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Type 2 Diabetes

    phase 1 · small molecule · completed

    1 trial →

34. MBX 4291

    MBX Biosciences

    Obesity

    phase 1 · small molecule · active

    1 trial →

35. MWN109 tablet

    Shanghai University of Traditional Chinese Medicine

    Overweight or Obesity

    phase 1 · small molecule · active

    1 trial →

36. Metabolically Armed CD19 CAR-T cells

    Anhui Provincial Hospital

    Acute Lymphoblastic Leukemia

    phase 1 · small molecule · active

    1 trial →

37. Metformin

    The First People's Hospital of Lianyungang

    Type2 Diabetes

    phase 1 · small molecule · active

    1 trial →

38. Midazolam

    ENANTA PHARMACEUTICALS INC

    NASH

    phase 1 · small molecule · completed

    1 trial →

39. Miricorilant

    CORCEPT THERAPEUTICS INC

    Non-alcoholic Steatohepatitis (NASH)

    phase 1 · small molecule · completed

    1 trial →

40. Miricorilant 150 mg

    CORCEPT THERAPEUTICS INC

    Nonalcoholic Steatohepatitis (NASH)

    phase 1 · small molecule · completed

    1 trial →

41. Mudan granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetic Peripheral Neuropathy Type 2

    phase 1 · small molecule · active

    1 trial →

42. NAT-022/BIO

    Dr. Falk Pharma GmbH

    Idiopathic or diabetic gastroparesis

    phase 1 · other · active

    1 trial →

43. NBI-6024

    NEUROCRINE BIOSCIENCES INC

    Type 1 Diabetes Mellitus

    phase 1 · small molecule · completed

    1 trial →

44. NN1436-7615

    NovoThirteen

    Type 2 diabetes

    phase 1 · other · active

    1 trial →

45. NN1471-5026

    NovoThirteen

    Diabetes mellitus type 2

    phase 1 · other · active

    1 trial →

46. NN1471-7712

    NovoThirteen

    Diabetes mellitus type 1

    phase 1 · other · active

    1 trial →

47. NN1644-7794

    NovoThirteen

    Type 1 diabetes mellitus

    phase 1 · other · active

    1 trial →

48. NN1644-8194

    NovoThirteen

    Diabetes type 1

    phase 1 · other · active

    1 trial →

Frequently asked questions